STAT+: 23andMe finds genetic changes appear to help predict response to GLP-1 drugs for weight loss

Data ReadoutpositiveGLP-1 drugsPositive

AI Analysis

Summary

23andMe identified genetic changes in two genes that may predict patient response to GLP-1 drugs for weight loss and likelihood of experiencing nausea or vomiting. This pharmacogenomic discovery could enable personalized treatment selection for GLP-1 therapies.

Outcome Details

Genetic changes in two genes appear to predict GLP-1 drug response for weight loss and adverse effects (nausea/vomiting)

Importance:6/10

Sentiment:

0.60

genetic_biomarkerGLP-1weight_losspharmacogenomicsprecision_medicine

Related Companies

$DMII

Read the original article

Published by STAT News on April 8, 2026 3:00 PM

Read Original